Aptorum Group share price today

(APM)

Aptorum Group share price is $0.86 & ₹73.27 as on 25 Dec 2024, 2.30 'hrs' IST

$0.86

▲

0.13

(17.9%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Aptorum Group share price in Dollar and Rupees. Guide to invest in Aptorum Group from India. Also see the sentimental analysis on Indian investors investing in Aptorum Group. Get details on the Indian mutual funds that are investing in Aptorum Group. Get Analyst recommendations and forecasts along with all the Aptorum Group's financials.

Aptorum Group share price movements

Today's Low: $0.73
Today's High: $0.88
$0.86
14.59%
Downside
Day's Volatility :16.53%
Upside
2.27%
52 Weeks Low: $0.46
52 Weeks High: $17.49
$0.86
46.51%
Downside
52 Weeks Volatility :97.37%
Upside
95.08%

Aptorum Group Returns

Period	Aptorum Group Ltd	Index (Russel 2000)
3 Months	-53.87%	0.0%
6 Months	-81.3%	0.0%
1 Year	-66.08%	0.0%
3 Years	-94.79%	-21.1%

Aptorum Group Key Statistics

in dollars & INR

Previous Close	$0.7336
Open	$0.7345
Today's High	$0.88
Today's Low	$0.7345
Market Capitalization	$4.9M
Today's Volume	$50.7K
52 Week High	$17.49
52 Week Low	$0.46
Revenue TTM	$431.4K
EBITDA	$-9.6M
Earnings Per Share (EPS)	$0.31
PE Ratio	2.79
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.4%

How to invest in Aptorum Group from India?

It is very easy for Indian residents to invest directly in Aptorum Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptorum Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptorum Group or APM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptorum Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptorum Group shares which would translate to 0.991 fractional shares of Aptorum Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptorum Group, in just a few clicks!

Returns in Aptorum Group for Indian investors in Rupees

Investment Value

₹1,00,000

Aptorum Group investment value today

Current value as on today

₹35,964

Returns

₹64,036

(-64.04%)

Returns from Aptorum Group Stock

₹66,275 (-66.27%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Aptorum Group

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aptorum Group on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 0% more investors are searching Aptorum Group in the last 30 days versus the previous period.

Global Institutional Holdings in Aptorum Group

Geode Capital Management, LLC
0.71%
Morgan Stanley - Brokerage Accounts
0.28%

Analyst Recommendation on Aptorum Group

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Aptorum Group(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptorum Group

What analysts predicted

Upside of 9202.33%

Current:

$0.86

Target:

$80.00

Insights on Aptorum Group

Price Movement
In the last 7 days, APM stock has moved up by 17.0%
APM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 90.1%
APM vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 120.0%
Price to Sales
ForAPM every $1 of sales, investors are willing to pay $9.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Aptorum Group Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$383.5K	-
Net Income	$-14.8M	↑ 482.22%
Net Profit Margin	-3.9K%	-

	FY19	Y/Y Change
Revenue	$535.2K	↑ 39.57%
Net Income	$-20.9M	↑ 40.61%
Net Profit Margin	-3.9K%	↓ 28.87%

	FY20	Y/Y Change
Revenue	$911.5K	↑ 70.32%
Net Income	$7.1M	↓ 133.89%
Net Profit Margin	775.29%	↑ 4672.13%

	FY21	Y/Y Change
Revenue	$1.5M	↑ 69.15%
Net Income	$-25.3M	↓ 457.84%
Net Profit Margin	-1.6K%	↓ 2415.5%

	FY22	Y/Y Change
Revenue	$1.3M	↓ 15.95%
Net Income	$-5.3M	↓ 78.98%
Net Profit Margin	-410.1%	↑ 1230.11%

	FY23	Y/Y Change
Revenue	$431.4K	↓ 66.71%
Net Income	$-2.8M	↓ 46.85%
Net Profit Margin	-654.8%	↓ 244.7%

	Q1 FY22	Q/Q Change
Revenue	$-1.3M	-
Net Income	$-2.2M	-
Net Profit Margin	177.14%	-

	Q2 FY22	Q/Q Change
Revenue	$527.5K	↓ 142.03%
Net Income	$-1.9M	↓ 15.19%
Net Profit Margin	-357.42%	↓ 534.56%

	Q1 FY23	Q/Q Change
Revenue	$768.4K	↑ 45.68%
Net Income	$-7.9M	↑ 319.8%
Net Profit Margin	-1.0K%	↓ 672.52%

	Q3 FY23	Q/Q Change
Revenue	$431.4K	↓ 43.86%
Net Income	$-5.5M	↓ 30.67%
Net Profit Margin	-1.3K%	↓ 242.05%

	FY18	Y/Y Change
Profit	$65.4K	-

	FY19	Y/Y Change
Profit	$-259.4K	↓ 496.37%

	FY20	Y/Y Change
Profit	$-103.5K	↓ 60.09%

	FY21	Y/Y Change
Profit	$81.9K	↓ 179.08%

	FY22	Y/Y Change
Profit	$80.1K	↓ 2.19%

	FY23	Y/Y Change
Profit	$10.6K	↓ 86.8%

	Q1 FY22	Q/Q Change
Profit	$-2.5M	-

	Q2 FY22	Q/Q Change
Profit	$-585.2K	↓ 76.46%

	Q1 FY23	Q/Q Change
Profit	$-542.2K	↓ 7.35%

	Q3 FY23	Q/Q Change
Profit	$-665.3K	↑ 22.71%

	Q1 FY24	Q/Q Change
Profit	$-454.6K	↓ 31.67%

	FY18	Y/Y Change
Operating Cash Flow	$-10.0M	↑ 73.54%
Investing Cash Flow	$-6.1M	↓ 147.35%
Financing Cash Flow	$25.5M	↑ 180.54%

	FY19	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 33.35%
Investing Cash Flow	$-108.1K	↓ 98.22%
Financing Cash Flow	$-7.3M	↓ 128.74%

	FY20	Y/Y Change
Operating Cash Flow	$-15.9M	↑ 19.05%
Investing Cash Flow	$1.8M	↓ 1804.74%
Financing Cash Flow	$12.4M	↓ 269.62%

	FY21	Y/Y Change
Operating Cash Flow	$-14.7M	↓ 8.04%
Investing Cash Flow	$16.5M	↑ 796.07%
Financing Cash Flow	$2.8M	↓ 77.61%

	Q1 FY22	Q/Q Change
Operating Cash Flow	$3.3B	↑ 0.0%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$32.8B	↑ 0.0%

	Q2 FY22	Q/Q Change
Operating Cash Flow	$-6.8M	↓ 100.2%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$3.0M	↓ 99.99%

Aptorum Group Technicals Summary

Sell

Neutral

Buy

Aptorum Group is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aptorum Group Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptorum Group Ltd	29.05%	-81.3%	-66.08%	-94.79%	-99.39%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptorum Group Ltd	2.79	2.79	NA	0.0	-0.37	-0.32	NA	4.8
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptorum Group Ltd	Buy	$4.9M	-99.39%	2.79	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Aptorum Group

aptorum group limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. the company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. it also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. aptorum group limited was incorporated in 2010 and is headquartered in london, the united kingdom.

Organization	Aptorum Group
Employees	3
CEO	Mr. Chung Yuen Huen
Industry	Health Technology

Management People of Aptorum Group

Name	Title
Mr. Chung Yuen Huen	Founder, CEO & Non-Executive Director
Mr. Kwok Kuen Wong	Head of Finance

Important FAQs about investing in Aptorum Group from India :

What is Aptorum Group share price today?

Aptorum Group share price today stands at $0.86, Open: $0.73 ; Previous Close: $0.73 ; High: $0.88 ; Low: $0.73 ; 52 Week High: $17.49 ; 52 Week Low: $0.46. The stock opens at $0.73, after a previous close of $0.73. The stock reached a daily high of $0.88 and a low of $0.73, with a 52-week high of $17.49 and a 52-week low of $0.46.

Can Indians buy Aptorum Group shares?

Yes, Indians can invest in the Aptorum Group (APM) from India.

With INDmoney, you can buy Aptorum Group at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptorum Group at zero transaction cost.

How can I buy Aptorum Group shares from India?

It is very easy to buy Aptorum Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptorum Group be purchased?

Yes, you can buy fractional shares of Aptorum Group with INDmoney app.

What are the documents required to start investing in Aptorum Group stocks?

To start investing in Aptorum Group, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.